What is CYP2D6? Why Does it Matter for Medication Safety?
4 June 2026
Have you ever wondered why the same medication works well for one person but causes side effects in another?
One possible explanation lies within a gene called CYP2D6.
CYP2D6 is one of the most clinically important genes in pharmacogenomics. It produces an enzyme that helps the body metabolise many commonly prescribed medications, including codeine, tramadol, antidepressants, antipsychotics, and certain cardiovascular drugs.
However, not everyone inherits the same CYP2D6 genetic profile.
The Four CYP2D6 Metaboliser Types
Based on their genetic makeup, individuals may be classified into four metaboliser groups:
Poor Metabolizers
Poor metabolisers have little or no CYP2D6 enzyme activity. Certain medications may remain in the body longer than expected, potentially increasing the risk of side effects.
Intermediate Metabolizers
Intermediate metabolisers have reduced enzyme activity and may process some medications more slowly than normal.
Normal Metabolizers
Normal metabolisers process medications at the expected rate and typically respond to medications as intended.
Ultra-Rapid Metabolizers
Ultrarapid metabolisers have increased CYP2D6 activity, causing some medications to be processed much faster than expected.
For medications such as codeine, this can result in excessive conversion to morphine and an increased risk of toxicity.
Why CYP2D6 Matters
CYP2D6 influences the metabolism of numerous medications used in everyday clinical practice.
Understanding an individual’s CYP2D6 status may help healthcare professionals make more informed decisions regarding medication selection, dosage considerations, and safety monitoring.
Can Genetic Testing Identify CYP2D6 Variants?
Yes. CYP2D6 influences the metabolism of numerous medications used in everyday clinical practice. Variations in this gene may affect how quickly or slowly certain medications are processed, which can influence treatment effectiveness and the risk of side effects.
One medication commonly affected by CYP2D6 is codeine. In some individuals, codeine may be converted into morphine more rapidly than expected, potentially leading to higher drug concentrations in the body.
This became particularly important following a widely cited case involving a breastfeeding mother prescribed codeine, where genetic differences in CYP2D6 played a role in a tragic clinical outcome. The case remains one of the most influential examples demonstrating why genetics matter in medication safety.
👉 Read more: Codeine and CYP2D6: Why Genetics Matter During Breastfeeding
Conclusion
CYP2D6 is just one of many genes that may influence how your body responds to medications.
PRECISE Pharmacogenomics (PGx) analyses clinically relevant genetic markers associated with medication metabolism and response, helping healthcare professionals gain additional insights when evaluating medication choices.
Interested in learning more about how your DNA may affect your response to medications? Contact Precision Diagnostics to explore whether PRECISE PGx may be suitable for you.
